This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Aug 1;30(8):1183-1184.

doi: 10.1093/annonc/mdz201.

The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine

S Loi¹

Affiliations

Affiliation

¹ Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: Sherene.loi@petermac.org.

PMID: 31287498
DOI: 10.1093/annonc/mdz201

Free article

Editorial

The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine

S Loi. Ann Oncol. 2019.

Free article

. 2019 Aug 1;30(8):1183-1184.

doi: 10.1093/annonc/mdz201.

Author

S Loi¹

Affiliation

¹ Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: Sherene.loi@petermac.org.

PMID: 31287498
DOI: 10.1093/annonc/mdz201

No abstract available

PubMed Disclaimer

Comment on

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cardoso F, et al. Ann Oncol. 2019 Aug 1;30(8):1194-1220. doi: 10.1093/annonc/mdz173. Ann Oncol. 2019. PMID: 31161190 No abstract available.

Similar articles

Genetics of personalized medicine: cancer and rare diseases.
Alves ITS, Condinho M, Custódio S, Pereira BF, Fernandes R, Gonçalves V, da Costa PJ, Lacerda R, Marques AR, Martins-Dias P, Nogueira GR, Neves AR, Pinho P, Rodrigues R, Rolo E, Silva J, Travessa A, Leite RP, Sousa A, Romão L. Alves ITS, et al. Cell Oncol (Dordr). 2018 Jun;41(3):335-341. doi: 10.1007/s13402-018-0379-3. Epub 2018 Apr 9. Cell Oncol (Dordr). 2018. PMID: 29633150
The lung and winding road: twists and turns on the way to personalized NSCLC therapy.
Milella M. Milella M. Curr Pharm Des. 2014;20(24):3861-2. doi: 10.2174/13816128113196660766. Curr Pharm Des. 2014. PMID: 24191957 No abstract available.
New insights on personalized cancer treatments: a report from the ESMO Congress.
Ciardiello F, Jezdic S. Ciardiello F, et al. Expert Rev Anticancer Ther. 2011 Jan;11(1):21-3. doi: 10.1586/era.10.212. Expert Rev Anticancer Ther. 2011. PMID: 21166507
The way to precision medicine of our team.
Xu F, Wang X, Jiang Z. Xu F, et al. Chin Clin Oncol. 2016 Jun;5(3):46. doi: 10.21037/cco.2016.05.03. Epub 2016 May 18. Chin Clin Oncol. 2016. PMID: 27197515 Review.
Precision Medicine in Breast Cancer.
Odle TG. Odle TG. Radiol Technol. 2017 Mar;88(4):401M-421M. Radiol Technol. 2017. PMID: 28298516 Review.

See all similar articles

Cited by

Deep Learning with Transformer or Convolutional Neural Network in the Assessment of Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Based on US Images: A Dual-Center Retrospective Study.
Jia Y, Wu R, Lu X, Duan Y, Zhu Y, Ma Y, Nie F. Jia Y, et al. Cancers (Basel). 2023 Jan 29;15(3):838. doi: 10.3390/cancers15030838. Cancers (Basel). 2023. PMID: 36765796 Free PMC article.
Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma.
Korpinen K, Autere TA, Tuominen J, Löyttyniemi E, Eigeliene N, Talvinen K, Kronqvist P. Korpinen K, et al. Breast Cancer Res Treat. 2025 Apr;210(2):463-475. doi: 10.1007/s10549-024-07584-4. Epub 2024 Dec 30. Breast Cancer Res Treat. 2025. PMID: 39739270 Free PMC article.
Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review.
Saleh GA, Batouty NM, Gamal A, Elnakib A, Hamdy O, Sharafeldeen A, Mahmoud A, Ghazal M, Yousaf J, Alhalabi M, AbouEleneen A, Tolba AE, Elmougy S, Contractor S, El-Baz A. Saleh GA, et al. Cancers (Basel). 2023 Oct 30;15(21):5216. doi: 10.3390/cancers15215216. Cancers (Basel). 2023. PMID: 37958390 Free PMC article. Review.
«Salivaomics» of Different Molecular Biological Subtypes of Breast Cancer.
Bel'skaya LV, Sarf EA. Bel'skaya LV, et al. Curr Issues Mol Biol. 2022 Jul 5;44(7):3053-3074. doi: 10.3390/cimb44070211. Curr Issues Mol Biol. 2022. PMID: 35877435 Free PMC article.
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study.
Kim DH, Lim Y, Kim S, Ock CY, Youk J, Kim M, Kim TM, Kim DW, Kim HJ, Koh J, Jung KC, Na KJ, Kang CH, Keam B. Kim DH, et al. Thorac Cancer. 2023 Oct;14(30):3001-3011. doi: 10.1111/1759-7714.15089. Epub 2023 Sep 7. Thorac Cancer. 2023. PMID: 37675597 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information